Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers year-to-date, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the same when compared to the […]
Venture Capital/Private Equity
Taris reboots with $32m round for bladder tech
A year after dealing its Liris bladder treatment to Allergan in a deal worth up to $588 million, Taris Biomedical raised another $32 million to put toward the implant, which is designed to deliver drugs directly to the bladder. Allergan paid $67.5 million in cash in August 2014 for Liris, a drug-device combination designed to deliver lidocaine to treat […]
